Creegan & Nassoura Financial Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.

Quarter-by-quarter ownership
Creegan & Nassoura Financial Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,222,320
+0.9%
12,0000.0%0.95%
+6.5%
Q2 2023$1,210,920
+4.0%
12,000
-5.1%
0.89%
+0.2%
Q1 2023$1,163,800
+1.4%
12,6500.0%0.89%
-0.3%
Q4 2022$1,147,608
+8.8%
12,650
-8.8%
0.90%
-2.2%
Q3 2022$1,055,000
-10.1%
13,8750.0%0.92%
-7.2%
Q2 2022$1,173,000
-9.4%
13,875
-5.9%
0.99%
+1.6%
Q1 2022$1,294,000
-27.6%
14,750
-27.8%
0.97%
-28.3%
Q4 2021$1,787,000
+7.0%
20,4250.0%1.35%
-5.1%
Q3 2021$1,670,000
-11.4%
20,425
-1.1%
1.42%
-11.5%
Q2 2021$1,884,000
+3.3%
20,650
-3.2%
1.61%
-0.9%
Q1 2021$1,823,000
-13.1%
21,325
-4.0%
1.63%
-19.5%
Q4 2020$2,099,000
+8.6%
22,2250.0%2.02%
-3.0%
Q3 2020$1,933,000
-0.4%
22,2250.0%2.08%
-4.8%
Q2 2020$1,941,000
+5.7%
22,225
-0.2%
2.19%
-8.8%
Q1 2020$1,837,000
-12.9%
22,2750.0%2.40%
+12.9%
Q4 2019$2,109,000
+2.1%
22,275
-14.8%
2.12%
-11.8%
Q3 2016$2,065,000
-4.7%
26,150
-0.4%
2.41%
-6.0%
Q2 2016$2,166,000
+11.4%
26,250
-2.2%
2.56%
+11.3%
Q1 2016$1,945,000
-17.0%
26,850
-1.4%
2.30%
-13.6%
Q4 2015$2,342,000
-6.8%
27,225
-0.4%
2.66%
-7.0%
Q3 2015$2,512,000
-6.9%
27,325
-0.4%
2.86%
+2.0%
Q2 2015$2,697,000
-0.3%
27,4250.0%2.81%
+1.0%
Q1 2015$2,704,000
+4.1%
27,425
-2.1%
2.78%
+4.9%
Q4 2014$2,597,00028,0252.65%
Other shareholders
NOVARTIS A G shareholders Q4 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders